Metraipolis › archive › dc_2e8a5bc18f14

Antioxidant, Hypotensive, and Antidiabetic Breakthroughs: Bromelain Hydrolysis Unlocks Quinoa's Peptide Potential - In Silico and In Vitro Approach — Europe PMC PMID:40854188

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40854188
DOI
10.1021/acs.jafc.5c03789
License (as archived)
solo-consultazione
Archived
2026-11-10T09:35:09.968Z
SHA-256 of the archived text
96742519b1358be6064772213d06e01456ac157dfb4d981fdc6db1c45789f9b6
Stable URL of this page
https://metraipolis.com/documento/dc_2e8a5bc18f14

How to cite

Antioxidant, Hypotensive, and Antidiabetic Breakthroughs: Bromelain Hydrolysis Unlocks Quinoa's Peptide Potential - In Silico and In Vitro Approach — Europe PMC PMID:40854188 — Europe PMC (en), https://europepmc.org/article/MED/40854188 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e8a5bc18f14 (Metraipolis archive dc_2e8a5bc18f14, sha256 96742519b1358be6064772213d06e01456ac157dfb4d981fdc6db1c45789f9b6)
BibTeX
@misc{dc2e8a5bc18f14,
  title = {Antioxidant, Hypotensive, and Antidiabetic Breakthroughs: Bromelain Hydrolysis Unlocks Quinoa's Peptide Potential - In Silico and In Vitro Approach — Europe PMC PMID:40854188},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40854188},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e8a5bc18f14; sha256 96742519b1358be6064772213d06e01456ac157dfb4d981fdc6db1c45789f9b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40854188. Agents can read the archived copy with the MCP tool read_document.